DK1880015T3 - Fremgangsmåde til identificering af CD4+-T-celle-antigener - Google Patents

Fremgangsmåde til identificering af CD4+-T-celle-antigener

Info

Publication number
DK1880015T3
DK1880015T3 DK06742659.3T DK06742659T DK1880015T3 DK 1880015 T3 DK1880015 T3 DK 1880015T3 DK 06742659 T DK06742659 T DK 06742659T DK 1880015 T3 DK1880015 T3 DK 1880015T3
Authority
DK
Denmark
Prior art keywords
identifying
cell antigens
antigens
directed
present
Prior art date
Application number
DK06742659.3T
Other languages
English (en)
Inventor
Josef Mautner
Uta Behrends
Slavoljub Milosevic
Original Assignee
Helmholtz Zentrum Muenchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen filed Critical Helmholtz Zentrum Muenchen
Application granted granted Critical
Publication of DK1880015T3 publication Critical patent/DK1880015T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK06742659.3T 2005-04-22 2006-04-24 Fremgangsmåde til identificering af CD4+-T-celle-antigener DK1880015T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05008924A EP1715346A1 (en) 2005-04-22 2005-04-22 Method of identifying CD4+ T cell antigens
PCT/EP2006/003759 WO2006111423A2 (en) 2005-04-22 2006-04-24 Method of identifying cd4+ t cell antigens

Publications (1)

Publication Number Publication Date
DK1880015T3 true DK1880015T3 (da) 2011-10-17

Family

ID=35058749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06742659.3T DK1880015T3 (da) 2005-04-22 2006-04-24 Fremgangsmåde til identificering af CD4+-T-celle-antigener

Country Status (8)

Country Link
US (1) US9341617B2 (da)
EP (2) EP1715346A1 (da)
AT (1) ATE518003T1 (da)
AU (1) AU2006237228B8 (da)
CA (1) CA2605933C (da)
DK (1) DK1880015T3 (da)
ES (1) ES2370336T3 (da)
WO (1) WO2006111423A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8313894B2 (en) 2008-07-01 2012-11-20 Genocea Biosciences, Inc. Antigen screening system
WO2016128060A1 (en) * 2015-02-12 2016-08-18 Biontech Ag Predicting t cell epitopes useful for vaccination
WO2018175505A1 (en) 2017-03-20 2018-09-27 Genocea Biosciences, Inc. Treatment methods
AU2019373241A1 (en) * 2018-10-29 2021-06-10 Genocea Biosciences, Inc. Treatment methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0110547D0 (en) * 2001-04-30 2001-06-20 Avidex Ltd Method

Also Published As

Publication number Publication date
US20090298056A1 (en) 2009-12-03
ATE518003T1 (de) 2011-08-15
CA2605933C (en) 2013-12-03
EP1880015A2 (en) 2008-01-23
AU2006237228B8 (en) 2011-03-10
EP1880015B1 (en) 2011-07-27
WO2006111423A2 (en) 2006-10-26
AU2006237228B2 (en) 2011-02-17
AU2006237228A1 (en) 2006-10-26
ES2370336T3 (es) 2011-12-14
WO2006111423A3 (en) 2007-01-04
US9341617B2 (en) 2016-05-17
CA2605933A1 (en) 2006-10-26
EP1715346A1 (en) 2006-10-25

Similar Documents

Publication Publication Date Title
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
DE602006006200D1 (de) Antikörper gegen 25-hydroxyvitamin d
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
CR9253A (es) Fijacion de la dosificacion de anticuerpos her
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EA201490454A1 (ru) Тернесит в качестве активатора для латентно-гидравлических и пуццолановых веществ
UY30662A1 (es) Método de cristalizacion discontinuo para cristalizar un anticuerpo anti-htnfalfa, cristales de anticuerpo obtenido por dicho método, composiciones que los conitenen y aplicaciones
EA201201288A1 (ru) Способ применения реактивов гриньяра
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
ECSP11011338A (es) Anticuerpos biespecíficos anti-her
DK201100184U1 (da) Method for immunizing an avian species
ATE497492T1 (de) Reinigung von montelukast
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
ECSP12011995A (es) Anticuerpos anti-her3 y usos de los mismos
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
MA35359B1 (fr) Lutte biologique contre les nématodes
BRPI0816911A8 (pt) Processo para preparação de 4-aminobut-2-enolidas
EA200702352A1 (ru) Новые композиции нутрицевтиков
ES2664972T3 (es) Moléculas de unión anti-Psl de Pseudomonas y usos de las mismas
MX337203B (es) Novedosas moleculas inhbidoras de jnk.
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
ATE532814T1 (de) Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
EA201000069A1 (ru) Новые гербициды
DK1926732T3 (da) Fremgangsmåde til fremstillingen af carbapenemforbindelser